← Eichor
Condition: Moderate Asthma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Moderate Asthma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Phase 3 · 32 location(s) · Inmunotek S.L. · NCT04891237Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Se
NA · 1 location(s) · Poitiers University Hospital · NCT05691218Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
EARLY_Phase 1 · 1 location(s) · University of Oklahoma · NCT06137040A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
Phase 3 · 5 location(s) · Université de Sherbrooke · NCT07309614ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
Phase 2 · 14 location(s) · Enveda Therapeutics · NCT07301255A Study of Step-up in Bronchial Asthma as a New End Point in Asthma Control (SURFE)
Phase N/A · 1 location(s) · Ain Shams University · NCT05632081Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma
Phase 3 · 1 location(s) · Shanghai Mabgeek Biotech.Co.Ltd · NCT06837922A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Phase 2 · 58 location(s) · Kymera Therapeutics, Inc. · NCT07323654Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
Phase 2 · 1 location(s) · Longbio Pharma · NCT07342803Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
Phase 4 · 3 location(s) · University of California, San Diego · NCT06385236Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma
Phase 2 · 13 location(s) · Oneness Biotech Co., Ltd. · NCT050089655HTP Regulation Of Asthma In Children
Phase 2 · 1 location(s) · Indiana University · NCT04160910A Study of CM310 in Subjects With Moderate to Severe Asthma
Phase 2/Phase 3 · 1 location(s) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · NCT05761028A Clinical Trial of Soluble Fiber for Asthma
Phase 2 · 1 location(s) · Phoenix Children's Hospital · NCT06372249Remission in Adults With Mild-to-moderate Asthma in Thailand
Phase N/A · 2 location(s) · Thammasat University · NCT07351916Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
Phase N/A · 1 location(s) · Gelb, Arthur F., M.D. · NCT00576069A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Hea
Phase 1 · 1 location(s) · Pfizer · NCT07660731Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
Phase 3 · 27 location(s) · Inmunotek S.L. · NCT04898283VENTURI (VENTilation Using Respiratory Imaging)
Phase 2 · 1 location(s) · University of Alabama at Birmingham · NCT07282886Can Astaxanthin Help Manage Asthma in POlluted Areas?
NA · 1 location(s) · Middlesex University · NCT07507682Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
Phase 2 · 167 location(s) · Chiesi Farmaceutici S.p.A. · NCT07301736Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
Phase 3 · 32 location(s) · Inmunotek S.L. · NCT04435990A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma
Phase 3 · 1 location(s) · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · NCT07372287A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Phase 2 · 132 location(s) · Pfizer · NCT06977581Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma
Phase 1/Phase 2 · 7 location(s) · Prana Therapies Inc · NCT07245368Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
Phase 4 · 1 location(s) · Sally E. Wenzel MD · NCT04743791Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
Phase 3 · 19 location(s) · Inmunotek S.L. · NCT07348302A Study of CDX-622 in Participants With Mild to Moderate Asthma
Phase 1 · 4 location(s) · Celldex Therapeutics · NCT07330778CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma
Phase 4 · 7 location(s) · Washington University School of Medicine · NCT07241117Study of CM512 Injection in Subjects With Moderate-to-severe Asthma
Phase 2 · 1 location(s) · Keymed Biosciences Co.Ltd · NCT07011524
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.